Learn More
Medchemexpress LLC Palbociclib hydrochloride | 571189-11-2 | 99.96% | C24H30ClN7O2 | 50 MG

Supplier: Medchemexpress LLC HY50767C50MG
Palbociclib hydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. It exhibits potent anti-proliferative activity and induces cell cycle arrest in cancer cells, making it suitable for research in HR-positive and HER2-negative breast cancer and hepatocellular carcinoma.
- Orally active selective CDK4 and CDK6 inhibitor
- Exhibits potent anti-proliferative activity
- Induces cell cycle arrest in cancer cells
- Suitable for research in HR-positive and HER2-negative breast cancer
- Suitable for research in hepatocellular carcinoma
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.